[HTML][HTML] 2024 ASCO 丨Dr. Li Yongqiang: Precise treatment and optimized management to maximize the benefits of mCRPC patients
E Profile - laitimes.com
… Metastatic castration-resistant prostate cancer (mCRPC) is … CDx or circulating tumor DNA
samples were analyzed using … therapy for prostate cancer, biomarkers and genetic testing …
samples were analyzed using … therapy for prostate cancer, biomarkers and genetic testing …
临床常见快速进展前列腺癌临床特点及研究进展
史本康， 陈守臻， 曲思凤， 王勇… - 山东大学学报(医学版 …, 2021 - yxbwk.njournal.sdu.edu.cn
… profiling identifies an androgen receptor activity-low, stemness program associated with
enzalutamide resistance [J]. Proc … Genomic correlates of clinical outcome in advanced prostate …
enzalutamide resistance [J]. Proc … Genomic correlates of clinical outcome in advanced prostate …
氟唑帕利治疗转移性去势抵抗性前列腺癌的初步有效性及安全性研究
韦煜， 张挺维， 何屹， 李俊， 毕建斌， 曾宇… - 中国癌症 …, 2021 - china-oncology.com
… 前列腺癌 (metastatic castration-resistant prostate cancer,mCRPC)… in prospective clinical
studies with larger sample size. … Prospective genomic profiling of prostate cancer across disease …
studies with larger sample size. … Prospective genomic profiling of prostate cancer across disease …
核受体HNF4α 通过调控雄激素受体表达促进去势抵抗性前列腺癌进展
王铸， 张颖， 张建文， 邓琼， 梁辉 - 中国癌症杂志, 2021 - china-oncology.com
… of castration-resistant prostate cancer. Methods: Oncomine analysis was used to characterize
the expression level of HNF4α in clinical samples of prostate cancer… (The Cancer Genome …
the expression level of HNF4α in clinical samples of prostate cancer… (The Cancer Genome …
通过生物信息学方法鉴定PTPRR 和JAG1 为去势抵抗性前列腺癌(CRPC) 的关键基因
J Wang, Y Wang, G Ren - Journal of Zhejiang University-SCIENCE B, 2020 - Springer
… novel genes in castration-resistant prostate cancer (CRPC), … -type R; TCGA: The Cancer
Genome Atlas; TPM: transcripts per … validate our results, the total sample size was still small due …
Genome Atlas; TPM: transcripts per … validate our results, the total sample size was still small due …
前列腺癌相關之人類基因甲基轉移酶突變體的結構和生化研究
黃薰禾 - 2023 - tdr.lib.ntu.edu.tw
… in the patients of metastatic castration-resistant prostate cancer (… (miRNA) regulation are
examples of epigenetic mechanisms … A groundbreaking discovery using whole genome bi-sulfite …
examples of epigenetic mechanisms … A groundbreaking discovery using whole genome bi-sulfite …
[HTML][HTML] 46 例前列腺癌患者的组织DNA 及血液ctDNA 测序分析
唐堂， 唐朋， 谭信韬， 冉强， 彭松， 刘秋礼， 徐静， 江军 - 2021 - aammt.tmmu.edu.cn
… in 31 tumor tissues and 32 peripheral blood specimens from … 癌(metastatic castration-resistant
prostate cancer, mCRPC)… 序列跟人类基因组序列(Human Genome Build 37)比较,如果在…
prostate cancer, mCRPC)… 序列跟人类基因组序列(Human Genome Build 37)比较,如果在…
2022 年度前列腺癌基础研究及临床诊疗新进展
潘剑， 朱耀， 戴波， 叶定伟 - 中国癌症杂志, 2023 - china-oncology.com
… alleles, somatic mutations, and 3D genomic architecture [J]. … patients with metastatic
castration-resistant prostate cancer: long… patients with metastatic castration-resistant prostate …
castration-resistant prostate cancer: long… patients with metastatic castration-resistant prostate …
[PDF][PDF] 肿瘤的液体活检研究进展
巢昱清， 朱小立， 陈桂芳 - 自然杂志, 2020 - nature.shu.edu.cn
… 治性前列腺癌 (castration-resistant prostate cancer, CRPC)的患者 … with prostate cancer
identified through whole-genome … tissue and plasma samples demonstrates differential subclonal …
identified through whole-genome … tissue and plasma samples demonstrates differential subclonal …